Suppr超能文献

系统分析小鼠异种移植模型揭示膜联蛋白 A1 是肿瘤基质中基因表达的调节剂。

Systems analysis of a mouse xenograft model reveals annexin A1 as a regulator of gene expression in tumor stroma.

机构信息

Sidney Kimmel Cancer Center and Proteogenomics Research Institute for Systems Medicine, San Diego, California, USA.

出版信息

PLoS One. 2012;7(10):e43551. doi: 10.1371/journal.pone.0043551. Epub 2012 Oct 15.

Abstract

Annexin A1 is a multi functional molecule which is involved in inflammation, innate and adaptive immune systems, tumor progression and metastasis. We have previously showed the impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1 knockout mice. While tumor is a piece of heterogeneous mass including not only malignant tumor cells but also the stroma, the importance of the tumor stroma for tumor progression and metastasis is becoming increasingly clear. The tumor stroma is comprised by various components including extracellular matrix and non-malignant cells in the tumor, such as endothelial cells, fibroblasts, immune cells, inflammatory cells. Based on our previous finding of pro-angiogenic functions for annexin A1 in vascular endothelial cell sprouting, wound healing, tumor growth and metastasis, and the previously known properties for annexin A1 in immune cells and inflammation, this study hypothesized that annexin A1 is a key functional player in tumor development, linking the various components in tumor stroma by its actions in endothelial cells and immune cells. Using systems analysis programs commercially available, this paper further compared the gene expression between tumors from annexin A1 wild type mice and annexin A1 knockout mice and found a list of genes that significantly changed in the tumor stroma that lacked annexin A1. This revealed annexin A1 to be an effective regulator in tumor stroma and suggested a mechanism that annexin A1 affects tumor development and metastasis through interaction with the various components in the microenvironment surrounding the tumor cells.

摘要

膜联蛋白 A1 是一种多功能分子,参与炎症、先天和适应性免疫系统、肿瘤进展和转移。我们之前已经证明,膜联蛋白 A1 敲除小鼠的肿瘤生长、转移、血管生成和伤口愈合受损。虽然肿瘤是一块异质的物质,不仅包括恶性肿瘤细胞,还包括基质,但肿瘤基质对肿瘤进展和转移的重要性越来越明显。肿瘤基质由各种成分组成,包括细胞外基质和肿瘤中的非恶性细胞,如内皮细胞、成纤维细胞、免疫细胞、炎症细胞。基于我们之前发现膜联蛋白 A1 在血管内皮细胞发芽、伤口愈合、肿瘤生长和转移中的促血管生成功能,以及之前已知的膜联蛋白 A1 在免疫细胞和炎症中的特性,本研究假设膜联蛋白 A1 是肿瘤发展的关键功能参与者,通过其在内皮细胞和免疫细胞中的作用将肿瘤基质中的各种成分联系起来。使用商业上可获得的系统分析程序,本文进一步比较了来自膜联蛋白 A1 野生型小鼠和膜联蛋白 A1 敲除小鼠的肿瘤之间的基因表达,发现了一组在缺乏膜联蛋白 A1 的肿瘤基质中显著改变的基因。这表明膜联蛋白 A1 是肿瘤基质中的有效调节剂,并提出了一种机制,即膜联蛋白 A1 通过与肿瘤细胞周围微环境中的各种成分相互作用,影响肿瘤的发展和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e5/3471933/9452e97d6186/pone.0043551.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验